Hirudin biosimilar (Rhein-Minapharm) | Interleukin Related interleukin-related.com

Product Name :
Hirudin biosimilar (Rhein-Minapharm)

Search keywords :
Rhein

drugId :
null

Target Vo:
Prothrombin

Target Vo Short Name :
PT

Moa_Name:
Prothrombin inhibitors

First Approval Country :
Egypt

First Approval Date Filter:
2006

Origin Company_Name :
Rhein Minapharm Biogenetics

Active Company_Name :
Rhein Minapharm Biogenetics

Active Indication_Name:
Venous Thrombosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRD4 Antibody
ERK1/2 Antibody
CD45 Antibody (YA800): CD45 Antibody (YA800) is a non-conjugated and Mouse origined monoclonal antibody about 147 kDa, targeting to CD45. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts